Feifan Wang

Ding Zou, Feifan Wang, Mengyu Ge et al.

The realization of Artificial General Intelligence (AGI) necessitates Embodied AI agents capable of robust spatial perception, effective task planning, and adaptive execution in physical environments. However, current large language models (LLMs) and multimodal LLMs (MLLMs) for embodied tasks suffer from key limitations, including a significant gap between model design and agent requirements, an unavoidable trade-off between real-time latency and performance, and the use of unauthentic, offline evaluation metrics. To address these challenges, we propose EmbodiedBrain, a novel vision-language foundation model available in both 7B and 32B parameter sizes. Our framework features an agent-aligned data structure and employs a powerful training methodology that integrates large-scale Supervised Fine-Tuning (SFT) with Step-Augumented Group Relative Policy Optimization (Step-GRPO), which boosts long-horizon task success by integrating preceding steps as Guided Precursors. Furthermore, we incorporate a comprehensive reward system, including a Generative Reward Model (GRM) accelerated at the infrastructure level, to improve training efficiency. For enable thorough validation, we establish a three-part evaluation system encompassing General, Planning, and End-to-End Simulation Benchmarks, highlighted by the proposal and open-sourcing of a novel, challenging simulation environment. Experimental results demonstrate that EmbodiedBrain achieves superior performance across all metrics, establishing a new state-of-the-art for embodied foundation models. Towards paving the way for the next generation of generalist embodied agents, we open-source all of our data, model weight, and evaluating methods, which are available at https://zterobot.github.io/EmbodiedBrain.github.io.

Feifan Wang

Past few years have witnessed the artificial intelligence inspired evolution in various medical fields. The diagnosis and treatment of gliomas -- one of the most commonly seen brain tumors with low survival rate -- rely heavily on the computer assisted segmentation process undertaken on the magnetic resonance imaging (MRI) scans. Although the encoder-decoder shaped deep learning networks have been the de facto standard style for semantic segmentation tasks in medical imaging analysis, enormous effort is still required to be spent on designing the detailed architecture of the down-sampling and up-sampling blocks. In this work, we propose a neural architecture search (NAS) based solution to brain tumor segmentation tasks on multimodal volumetric MRI scans. Three sets of candidate operations are composed respectively for three kinds of basic building blocks in which each operation is assigned with a specific probabilistic parameter to be learned. Through alternately updating the weights of operations and the other parameters in the network, the searching mechanism ends up with two optimal structures for the upward and downward blocks. Moreover, the developed solution also integrates normalization and patching strategies tailored for brain MRI processing. Extensive comparative experiments on the BraTS 2019 dataset demonstrate that the proposed algorithm not only could relieve the pressure of fabricating block architectures but also possesses competitive feasibility and scalability.

Feifan Wang, Runzhou Jiang, Liqin Zheng et al.

Past few years have witnessed the prevalence of deep learning in many application scenarios, among which is medical image processing. Diagnosis and treatment of brain tumors requires an accurate and reliable segmentation of brain tumors as a prerequisite. However, such work conventionally requires brain surgeons significant amount of time. Computer vision techniques could provide surgeons a relief from the tedious marking procedure. In this paper, a 3D U-net based deep learning model has been trained with the help of brain-wise normalization and patching strategies for the brain tumor segmentation task in the BraTS 2019 competition. Dice coefficients for enhancing tumor, tumor core, and the whole tumor are 0.737, 0.807 and 0.894 respectively on the validation dataset. These three values on the test dataset are 0.778, 0.798 and 0.852. Furthermore, numerical features including ratio of tumor size to brain size and the area of tumor surface as well as age of subjects are extracted from predicted tumor labels and have been used for the overall survival days prediction task. The accuracy could be 0.448 on the validation dataset, and 0.551 on the final test dataset.